Michael Lipscomb

Michael Lipscomb practices at Wellstar North Fulton Medical Center in Roswell, Georgia, part of Wellstar Health System.

Michael Lipscomb's NPI, 1124128376, was assigned on September 25, 2006. Michael Lipscomb holds Georgia license 49463.

Michael Lipscomb's primary practice is Wellstar North Fulton Medical Center, at 3000 Hospital Boulevard, Roswell, GA 30076 in Fulton County. The practice phone is (770) 751-2500.

Michael Lipscomb's primary practice is Wellstar North Fulton Medical Center in Roswell, Georgia, part of Wellstar Health System. The medical group on file is North Fulton Emergency Physicians, LLC. Dmand AI also links Michael Lipscomb to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Lipscomb practices. Vendor and product names are available with a free account.

Emergency medicine is Michael Lipscomb's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Michael Lipscomb is licensed in Georgia.

CMS data shows 284 Medicare services from Michael Lipscomb across 4 procedure codes in 2024, for 203 Medicare patients. Medicare paid $24,314 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 203 Medicare patients who saw Michael Lipscomb in 2024. The largest group is 75 to 84, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Lipscomb's median patient age at 58, with 58% women.

In 2024, Michael Lipscomb wrote 144 Medicare Part D claims for 83 patients. 91% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $159 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Michael Lipscomb for performance year 2024, reported through an alternative payment model (APM).

CMS Open Payments shows 9 general payments to Michael Lipscomb from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $122.